PALO ALTO, Calif. April 25, 2012
Siemens Healthcare will similarly represent Varian equipment and software for radiotherapy and radiosurgery within its offerings to its healthcare customers. This will enable the companies to offer comprehensive solutions to support the entire clinical workflow from imaging to treatment. Siemens will continue to service and support its global installed base of approximately 2,000 medical linear accelerators. The agreement will give Siemens customers more choices for therapy equipment, including smooth transition and interface to Varian equipment, as aging accelerators are due for replacement.
Furthermore, Varian and Siemens will develop interfaces that will enable connecting Varian’s ARIA® oncology information system software with Siemens accelerators and imaging systems to give clinics more options for improving workflow and streamlining their operations. The collaboration enables Varian and Siemens to co-develop and offer cancer treatment centers new imaging and treatment solutions utilizing the strengths and technology of both companies.
"With this step under Siemens’ Healthcare Agenda 2013, we aim to strengthen our position as Imaging Partner of Choice in Radiation Oncology," said Walter Marzendorfer CEO of Siemens Radiation Oncology and Computed Tomography. "Through this collaboration, Siemens will continue to serve the global radiation oncology business and help improve the treatment of cancer patients around the globe with high-quality imaging and treatment solutions that utilize our core competency and engineering excellence in imaging."
ABOUT SIEMENS HEALTHCARE
September 30 12.5 billion euros 1.3 billion euros www.siemens.com/healthcare.
ABOUT VARIAN MEDICAL SYSTEMS
VARIAN MEDICAL SYSTEMS FORWARD LOOKING STATEMENTS
Except for historical information, this news release contains forward-looking statements about Varian within the meaning of the Private Securities Litigation Reform Act of 1995. Statements related to Varian’s future business; financial performance; expectations; future events and developments; and any statements using the terms "will," "could," "believe," "expects," "enhance," "expand," "accelerate," or similar statements are forward-looking statements. Such statements are based on the current expectations and certain assumptions of Varian’s management, and are, therefore, subject to certain risks and uncertainties. A variety of factors, many of which are beyond Varian’s control, affect Varian’s operations, performance, business strategy and results and could cause the actual results, performance or achievements of Varian to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements or anticipated on the basis of historical trends. These factors include in particular, but are not limited to, demand for Varian’s and Siemens’ products, or any combination thereof; Varian’s ability to develop and commercialize new products; Varian’s and Siemens’ ability to meet regulatory regulations or procedures; Varian’s ability to protect the company’s intellectual property; and the other risks listed from time to time in Varian’s filings with the Securities and Exchange Commission, which by this reference are incorporated herein. These forward-looking statements represent Varian’s judgment as of the date of this press release. Varian neither intends, nor assumes any obligation, to update or revise these forward-looking statements in light of new information, future events, or otherwise.
SIEMENS HEALTHCARE NOTES AND FORWARD-LOOKING STATEMENTS
This document contains statements related to our future business and financial performance and future events or developments involving Siemens that may constitute forward-looking statements. These statements may be identified by words such as "expects," "looks forward to," "anticipates," "intends," "plans," "believes," "seeks," "estimates," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to stockholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements are based on the current expectations and certain assumptions of Siemens’ management, and are, therefore, subject to certain risks and uncertainties. A variety of factors, many of which are beyond Siemens’ control, affect Siemens’ operations, performance, business strategy and results and could cause the actual results, performance or achievements of Siemens to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements or anticipated on the basis of historical trends. These factors include in particular, but are not limited to, the matters described in Item 3: Risk factors of our most recent annual report on Form 20-F filed with the SEC, in the chapter "Risks" of our most recent annual report prepared in accordance with the German Commercial Code, and in the chapter "Report on risks and opportunities" of our most recent interim report.
Due to rounding, numbers presented throughout this and other documents may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.
SOURCE Varian Medical Systems